HC Surgical Specialists Limited Share Price

Equities

1B1

SG1DC2000004

Healthcare Facilities & Services

Market Closed - Singapore S.E. 06:38:49 24/04/2024 BST 5-day change 1st Jan Change
0.26 SGD 0.00% Intraday chart for HC Surgical Specialists Limited 0.00% -13.33%

Financials

Sales 2022 19.42M 14.28M 1.14B Sales 2023 19.4M 14.27M 1.14B Capitalization 59.56M 43.8M 3.49B
Net income 2022 6M 4.41M 352M Net income 2023 2M 1.47M 117M EV / Sales 2022 3.56 x
Net cash position 2022 910K 669K 53.36M Net cash position 2023 5.03M 3.7M 295M EV / Sales 2023 2.81 x
P/E ratio 2022
11 x
P/E ratio 2023
20.4 x
Employees -
Yield 2022
5.53%
Yield 2023
5%
Free-Float 18.14%
More Fundamentals * Assessed data
Dynamic Chart
Singapore Shares End Week in Red; Totm Technologies Shares Rise 9% Despite Wider Fiscal H1 Loss MT
HC Surgical Specialists' Attributable Profit Zooms 68% in Fiscal H1 MT
HC Surgical Specialists Limited Declares Interim Dividend for the Financial Year Ending 31 May 2024, Payable on 13 March 2024 CI
HC Surgical Specialists Limited Reports Earnings Results for the Half Year Ended November 30, 2023 CI
HC Surgical Specialists Strikes Off Dormant Unit MT
HC Surgical Specialists Limited Announces Change of Registered Office Address CI
HC Surgical's Joint Venture Secures Regulatory Approval for Second Orthopedic Center MT
HC Surgical's Associated Company Gets Approval to Operate Orthopedic Center in Singapore MT
HC Surgical Specialists Limited Approves A Final Dividend for the Financial Year Ended 31 May 2023 CI
Singapore Index Starts Week in Positive Territory; Geo Energy Resources Soars 13% on Securing $220 Million Loan MT
HC Surgical Specialists Issues Nearly 5 Million Consideration Shares for Jason Lim Endoscopy Acquisition MT
HC Surgical Specialists Limited Proposes Final Dividend for the Financial Year Ended 31 May 2023 CI
HC Surgical Specialists Unit Enters Tenancy Agreement with CEO's Firm MT
HC Surgical Specialists' Attributable Profit Drops 58% in Fiscal H2 MT
HC Surgical Specialists Limited Recommends Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 31 May 2023, Payable on 24 November 2023 CI
More news
3 months-11.86%
6 months-21.21%
Current year-13.33%
More quotes
1 week
0.26
Extreme 0.26
0.26
1 month
0.26
Extreme 0.255
0.29
Current year
0.24
Extreme 0.24
0.32
1 year
0.24
Extreme 0.24
0.48
3 years
0.24
Extreme 0.24
0.58
5 years
0.24
Extreme 0.24
0.59
10 years
0.24
Extreme 0.24
0.75
More quotes
Managers TitleAgeSince
Chief Executive Officer - 31/08/15
Director of Finance/CFO - 14/02/16
Chief Operating Officer 33 31/05/17
Members of the board TitleAgeSince
Director/Board Member - 27/09/16
Chairman 60 27/09/16
Chief Tech/Sci/R&D Officer 64 31/08/15
More insiders
Date Price Change Volume
24/04/24 0.26 0.00% 30,000
23/04/24 0.26 0.00% 80,100
22/04/24 0.26 0.00% 10,000

Delayed Quote Singapore S.E., April 24, 2024 at 06:38 am

More quotes
HC Surgical Specialists Limited is a Singapore-based investment holding company. The Company’s subsidiaries are engaged in providing medical services. It is primarily involved in the provision of endoscopic procedures, including gastroscopies and colonoscopies and general surgery services, with a focus on colorectal procedures across a network of 16 clinics located throughout Singapore. Its businesses include facilities and clinics, and specialist surgeons and general practitioners. It operates a network of clinics located throughout Singapore, in both residential areas and central areas, which are accessible to the public for consultation. Its clinics have facilities needed to perform a range of procedures on-site, including endoscopic procedures and other minor surgical services. Its subsidiaries include Heah Sieu Min (Mt E) Pte. Ltd., Heah Sieu Min (Bukit Batok) Pte. Ltd., CKH (Farrer Park) Pte. Ltd., HC (Siglap) Pte. Ltd., HC (TPY) Pte. Ltd., Malcolm Lim Pte. Ltd. and other.
More about the company